{"title": "Acr\u00f3nimos", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "1999-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "|P || || |\n|P ||phosphoprotein ||fosfoprote\u00edna |\n|P ||phosphorylation ||fosforilaci\u00f3n |\n|P ||platelet ||plaquetas |\n|P/SBF ||pulmonary/systemic blood flow ||corriente sangu\u00ednea pulmonar/sist\u00e9mica |\n|p38MAP ||p38 mitogen-activated protein ||prote\u00edna cinasa activada por mit\u00f3geno p38 |\n|Pa ||active phosphorylase ||fosforilasa activa |\n|PA ||plasma aldosterone ||aldosterona plasm\u00e1tica |\n|PA ||plasminogen activator ||activador de plasmin\u00f3geno |\n|PA ||primary aldosteronism ||aldosteronismo primario |\n|PA ||pulmonary artery ||presi\u00f3n de la arteria pulmonar |\n|PABA ||p-aminobenzoic acid ||\u00e1cido p-aminobenzoico |\n|PABP2 ||poly-RNA binding protein ||prote\u00edna de uni\u00f3n a poli-RNA |\n|PAC ||pulmonary artery catheter ||cat\u00e9ter en la arteria pulmonar |\n|PACM ||pregnancy-associated cardiomyopathy ||miocardiopat\u00eda vinculada con el embarazo |\n|PACAP ||pituitary adenylate-cyclase activating peptide ||p\u00e9ptido activador de la adenilato ciclasa hipofisaria |\n|PaCO2 ||partial pressure of carbon dioxide in arterial blood ||presi\u00f3n parcial arterial de di\u00f3xido de carbono |\n|PAD ||peripheral arterial disease ||arteriopat\u00eda perif\u00e9rica |\n|PADI4 ||peptidyl arginine deaminase type IV ||peptidilarginina desiminasa tipo IV |\n|PAF ||platelet activating factor ||factor activador de plaquetas |\n|PAF ||progressive autonomic failure ||insuficiencia auton\u00f3mica progresiva |\n|PAF ||pure autonomic failure ||insuficiencia pura del sistema aut\u00f3nomo |\n|PAG ||periaqueductal gray area ||\u00e1rea gris periacueductal |\n|PAH ||primary adrenal hyperplasia ||hiperplasia suprarrenal primaria |\n|PAH ||primary alveolar hypoventilation ||hipoventilaci\u00f3n alveolar primaria |\n|PAH ||pulmonary arterial hypertension ||hipertensi\u00f3n arterial pulmonar |\n|PAH ||phenylalanine hydroxylase ||fenilalanina hidroxilasa |\n|PaI ||pathogenicity island ||isla de patogenicidad |\n|PAI ||plasminogen activator inhibitor ||inhibidor del activador de plasmin\u00f3geno |\n|PAI-1 ||plasminogen activator inhibitor 1 ||inhibidor del activador de plasmin\u00f3geno 1 |\n|PAI-3 ||plasminogen activator inhibitor-3 ||inhibidor del activador del plasmin\u00f3geno 3 |\n|PAIR ||percutaneous aspiration, infusion of solicidal agents ||aspiraci\u00f3n percutanea con infusion de escolicidas |\n|PALCAM ||Listeria Selective Agar u Oxford Agar || |\n|PAM ||potassium-aggravated myotonia ||mioton\u00eda agravada por potasio |\n|PAM ||primary amebic meningoencephalitis ||meningoencefalitis amebiana primaria |\n|PAMP ||pathogen-associated molecular patterns ||modelos moleculares asociados a microorganismos pat\u00f3genos |\n|PAN ||polyarteritis nodosa ||poliarteritis nudosa |\n|P-ANCA ||perinuclear antineutrophil cytoplasmic antibody ||anticuerpo perinuclear contra el citoplasma de neutr\u00f3filos |\n|PANDAS ||Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infection || |\n|PanIN ||pancreatic intraepithelial neoplasia ||neoplasia intraepitelial pancre\u00e1tica |\n|Pao2 ||partial pressure of oxygen in arterial blood ||presi\u00f3n parcial de O2 en la sangre arterial |\n|PaP ||phosphorylase to phosphatase ||fosforilasa a fosfatasa |\n|PAP ||pulmonary alveolar proteinosis ||proteinosis alveolar pulmonar |\n|PAP ||pulmonary artery pressure ||presi\u00f3n arterial pulmonar |\n|PAP ||prostatic acid phosphatase ||fosfatasa \u00e1cida prost\u00e1tica |\n|PAPA ||pyogenic arthritis with poyoderma gangrenosum and acne ||artritis pi\u00f3gena con pioderma gangrenoso y acn\u00e9 |\n|PAPm ||pulmonary artery pressure-mean ||presi\u00f3n de arteria pulmonar media |\n|PAPR ||powered air-purifyng respirators ||respiradores-purificador de aire |\n|PAPVR ||partial anomalous pulmonary venous return ||retorno venoso pulmonar an\u00f3malo parcial |\n|PAR-1 ||protease activated receptor-1 ||receptor activado de la proteasa de tipo 1 |\n|PARC ||pulmonary and activation-regulated chemokine ||quimiocina pulmonar y de activaci\u00f3n regulada |\n|PARP ||poly-A ribose polymerase ||poli-A ribosa polimerasa |\n|PARPi ||poly-ADP ribose polymerase inhibitors ||inhibidores de la poli ADP ribosa polimerasa |\n|PAS ||para-aminosalicylic acid ||\u00e1cido paraaminosalic\u00edlico |\n|PAS ||periodic acid-Schiff ||\u00e1cido pery\u00f3dico y colorante de Schiff |\n|PAS/D ||pulmonary artery systolic/diastolic ||sist\u00f3lica/diast\u00f3lica de arteria pulmonar |\n|PASG ||pneumatic antishock garment ||traje neum\u00e1tico antichoque |\n|PASP || ||Presi\u00f3n sist\u00f3lica arterial pulmonar |\n|PAWP ||pulmonary artery wedge pressure ||presi\u00f3n de enclavamiento de la arteria pulmonar |\n|PAX-8 ||paired homeobox-8 ||homeosecuencias emparejadas 8 |\n|Pb ||inactive phosphorylase ||fosforilasa inactiva |\n|PBC ||primary biliary cirrosis ||cirrosis biliar primaria |\n|PBG ||porphobilinogen ||porfobilin\u00f3geno |\n|PbKa ||active phosphorylase b kinase ||fosforilasa b cinasa activa |\n|PbKb ||inactive phosphorylase b kinase ||fosforilasa b cinasa inactiva |\n|PBP ||penicillin-binding protein ||prote\u00edna de uni\u00f3n a la penicilina |\n|PBP ||primary bacterial peritonitis ||peritonitis bacteriana primaria |\n|PBP2a ||penicillin-binding protein ||prote\u00edna de uni\u00f3n a penicilina |\n|PBT ||peripheral blood T cells ||linfocitos T de sangre perif\u00e9rica |\n|PBW ||predicted body weight ||peso corporal previsible |\n|PC ||paramyotonia congenita ||paramioton\u00eda cong\u00e9nita |\n|PC ||platelet concentrates ||concentrados de plaquetas |\n|PC1 ||prohormone convertase 1 ||convertasa prohormonal 1 |\n|PCA ||patient-controlled analgesia ||analgesia regulada por el paciente |\n|PCA ||posterior cerebral artery ||arteria cerebral posterior |\n|P-CAB ||potassium-competitive acid pump antagonists ||antagonista competitivo de la bomba de potasio-\u00e1cido |\n|PCC ||prothrombin complex concentrates ||concentrados de complejo de protrombina |\n|PCD ||paraneoplastic cerebellar degeneration ||degeneraci\u00f3n cerebelosa paraneopl\u00e1sica |\n|PCEC ||purified chick embryo cell vaccine ||vacuna de c\u00e9lulas de embri\u00f3n de pollo purificada |\n|PCFT ||protein coupled folate transported ||transportador de folato acoplado a prote\u00ednas |\n|PCH ||paroxysmal cold hemoglobinuria ||criohemoglobinuria parox\u00edstica |\n|PCI ||percutaneous coronary intervention ||intervenci\u00f3n coronaria percut\u00e1nea |\n|PCI ||prophylactic cranial irradiation ||irradiaci\u00f3n craneal profil\u00e1ctica |\n|PCI ||protein C inhibitor ||inhibidor de la prote\u00edna C |\n|PCI ||percutaneous coronary intervention ||intervenci\u00f3n coronaria percut\u00e1nea |\n|PCM ||protein-calorie malnutrition ||malnutrici\u00f3n proteinicocal\u00f3rica |\n|PCNA ||proliferating cell nuclear antigen ||ant\u00edgeno nuclear de c\u00e9lulas en proliferaci\u00f3n |\n|PCNSL ||primary central nervous system lymphoma ||linfoma primario del sistema nervioso central |\n|PCOS ||polycystic ovarian syndrome ||s\u00edndrome de ovarios poliqu\u00edsticos |\n|PCP ||phencyclidine ||fenciclidina |\n|PCP ||P. carinii pneumonia ||neumon\u00eda por Pneumocystis carinii |\n|PcP ||Pneumocystis pneumonia ||neumon\u00eda por Pneumocystis |\n|PCPT ||PProstate Cancer Prevention Trial || |\n|PCR ||polymerase chain reaction ||reacci\u00f3n en cadena de la polimerasa |\n|PCSK9 ||proprotein convertase subtilisin/kexin type 9 ||subtilisina de convertasa (una proprote\u00edna)/kexina de tipo 9 |\n|pCT ||perfusion computed tomography ||tomograf\u00eda computarizada de perfusi\u00f3n |\n|PCT ||Primary Care Trusts ||fideicomisos de atenci\u00f3n primaria |\n|PCT ||porphyria cutanea tarda ||porfiria cut\u00e1nea tard\u00eda |\n|PCT ||procalcitonin ||procalcitonina |\n|PCV ||polysaccharide-protein conjugate vaccine ||vacuna conjugada de polisac\u00e1rido-prote\u00edna contra el neumococo |\n|PCV ||Peace Corps Volunteer ||Voluntarios de Cuerpos de Paz |\n|PCV ||pneumococcal conjugate vaccine ||vacuna de conjugado neumoc\u00f3cico |\n|PCV ||pressure-control ventilation ||ventilaci\u00f3n con control de presi\u00f3n |\n|PCV7 ||7-valent pneumococcal conjugate vaccine ||vacuna neumoc\u00f3cica heptavalente conjugada con prote\u00edna |\n|PCWP ||pulmonary capillary wedge pressure ||presi\u00f3n capilar pulmonar de enclavamiento |\n|Pd ||pancreatic duct ||conducto de Wirsung o pancre\u00e1tico |\n|PD ||Parkinson\u2019s disease ||enfermedad de Parkinson |\n|PD ||peritoneal dialysis ||di\u00e1lisis peritoneal |\n|PD ||potential difference ||diferencia de potencial |\n|PD ||programmed death ||muerte programada |\n|PD-1 ||program death-1 ||muerte celular programada-1 |\n|PDA ||patent ductus arteriosus ||conducto arterioso persistente |\n|pCD ||plasmacytoid dendritic cells ||c\u00e9lulas dendr\u00edticas plasmacitoides |\n|PDC ||pyruvate dehydrogenase complex ||complejo de piruvato deshidrogenasa |\n|PDC ||potentially diagnostic clues ||indicios con potencial diagnostico |\n|PDC-E2 ||pyruvate dehydrogenase complex-E2 ||E2 piruvato deshidrogenasa |\n|PDD ||Parkinson disease dementia ||demencia por enfermedad de Parkinson |\n|PDE-5 ||phosphodiesterase type 5 ||fosfodiesterasa de tipo 5 |\n|PDEV ||purified duck embryo vaccine ||vacuna de embri\u00f3n de pato purificada |\n|PDGF ||platelet-derived growth factor ||factor de crecimiento derivado de plaquetas |\n|PDGF-BB ||platelet-derived growth factor B ||factor B de crecimiento derivado de plaquetas |\n|PDGFR ||platelet-derived growth factor receptor ||receptor del factor de crecimiento derivado de plaquetas |\n|PDGFR\u03b1 ||platelet derived growth factor receptor-\u03b1 ||receptor alfa del factor de crecimiento derivado de plaquetas |\n|PDH ||progressive disseminated histoplasmosis ||histoplasmosis diseminada progresiva |\n|PDMP ||prescription drug monitoring programs ||programas de vigilancia farmacol\u00f3gica de prescripci\u00f3n |\n|PDPT ||patient\u2019s delivery of partner\u2019s therapy ||tratamiento suministrado por el propio paciente |\n|PDT ||photodynamic therapy ||tratamiento fotodin\u00e1mico |\n|PE ||phenytoin equivalents ||equivalentes de difenilhidantoinato |\n|PE ||physical examination ||exploraci\u00f3n f\u00edsica |\n|PE ||plasma exchange ||intercambio de plasma |\n|PE ||pulmonary embolism ||embolia pulmonar |\n|PEA ||phosphoethanolamine ||fosfoetanolamina |\n|PEA ||pulseless electrical activity ||actividad el\u00e9ctrica sin pulsos |\n|PEA ||organized electrical activity ||actividad el\u00e9ctrica organizada |\n|PEACH ||Pelvic Inflammatory Disease Evaluation and Clinical Health || |\n|PECAM ||platelet-endothelial cell adhesion molecule ||mol\u00e9cula de adhesi\u00f3n celular de plaquetas-endotelio |\n|PEEP ||positive end-expiratory pressure ||presi\u00f3n positiva al final de la espiraci\u00f3n |\n|PEF ||peak expiratory flow ||flujo espiratorio m\u00e1ximo |\n|PEFR ||peak expiratory flow rate ||velocidad m\u00e1xima de flujo espiratorio |\n|PEG ||polyethylene glycol ||polietilenglicol |\n|PEG ||percutaneous endoscopic gastrostomy ||gastrostom\u00eda endosc\u00f3pica percut\u00e1nea |\n|PEG IFN ||PEG interferon ||interfer\u00f3n pegilado |\n|PEG-ADA ||PEG-adenosin deaminase ||desaminasa de adenosina pegilada |\n|PEI ||percutaneous ethanol injection ||inyecci\u00f3n percut\u00e1nea de etanol |\n|PELD ||Pediatric End-Stage Liver Disease || |\n|PEM ||paraneoplastic encephalomyelitis ||encefalomielitis paraneopl\u00e1sica |\n|PEM ||protein-energy malnutrition ||malnutrici\u00f3n proteinicocal\u00f3rica |\n|PENS ||percutaneous electrical nerve stimulation ||estimulaci\u00f3n nerviosa el\u00e9ctrica percut\u00e1nea |\n|PEO ||progressive external ophthalmoplegia ||oftalmoplej\u00eda externa progresiva |\n|PEP ||postexposure prophylaxis ||profilaxia despu\u00e9s de exposici\u00f3n |\n|PEPFAR ||President\u2019s Emergency Plan for AIDS Relief || |\n|PEPI ||Postmenopausal Estrogen/Progestin Interventions ||Intervenciones con estr\u00f3geno/progest\u00e1geno posmenop\u00e1usico |\n|PERRLA ||pupils equal, round, reactive to light and accommodation ||pupilas isoc\u00f3ricas, redondas y reactivas a la luz y la acomodaci\u00f3n |\n|PET || || |\n|PET ||pancreatic endocrine tumors ||tumores endocrinos pancre\u00e1ticos |\n|PET ||positron emission tomography ||tomograf\u00eda por emisi\u00f3n de positrones |\n|PF ||patellofemoral ||femororrotuliano |\n|PF ||pemphigus foliaceus ||p\u00e9nfigo foli\u00e1ceo |\n|PF ||platelet factor ||factor plaquetario |\n|PF ||pleural fluid ||l\u00edquido pleural |\n|PF4 ||platelet factor 4 ||factor plaquetario 4 |\n|PFAFA ||periodic fever with aphthous ulcers, pharyngitis, and cervical adenopathy ||sindrome de fiebre peri\u00f3dica con \u00falceras aftosas, faringitis y adenopat\u00eda cervical |\n|PFAPA ||periodic fever, aphthous ulcers, pharyngitis, cervical adenopathy ||fiebre peri\u00f3dica con \u00falceras aftosas, faringitis y adenopat\u00eda cervical |\n|PFGE ||pulsed-field gel electrophoresis ||electroforesis en gel con campo pulsado |\n|PFIC ||progressive familial intrahepatic cholestasis ||colestasis intrahep\u00e1tica familiar progresiva |\n|PFO ||patent foramen ovale ||persistencia del agujero oval |\n|PFOR ||pyruvate-ferredoxin oxidoreductase ||oxidorreductasa de piruvato-ferredoxina |\n|PFPA ||periodic fever, adenitis, pharyngitis, aphthae ||fiebre peri\u00f3dica, adenitis, faringitis, aftas |\n|pFRG ||parafacial respiratory group ||grupo respiratorio parafacial |\n|PFS ||progression-free survival ||supervivencia sin progresi\u00f3n de la enfermedad |\n|PFT ||pulmonary function testing ||pruebas funcionales respiratorias |\n|PG ||plasma glucose ||glucosa plasm\u00e1tica |\n|PG ||phemphigoid gestationis ||penfigoide gestacional |\n|PG ||prostaglandin ||prostaglandina |\n|PG ||peptidoglycan ||peptidoglucano |\n|PG ||pyoderma gangraenosum ||piodermia gangrenosa |\n|PGA ||polyglandular autoimmune syndrome ||s\u00edndrome poliglandular autoinmunitario |\n|PGC ||primordial germ cells ||c\u00e9lulas germinales primordiales |\n|PGE ||prostaglandin E ||prostaglandina E |\n|PGE1 ||prostaglandin E1 ||prostaglandina E1 |\n|PGE2 ||prostaglandin E2 ||prostaglandina E2 |\n|PGL ||progressive generalized lymphadenopathy ||linfadenopat\u00eda generalizada persistente |\n|PGL ||paraganglioma syndrome ||s\u00edndromes de paragangliomas |\n|PGP ||P-glycoprotein ||glucoprote\u00edna P |\n|PGU ||postgonococcal urethritis ||uretritis posgonoc\u00f3cica |\n|PH ||paroxysmal hemicrania ||hemicr\u00e1nea parox\u00edstica |\n|PH ||pleckstrin homology ||homolog\u00eda de pleckstrina |\n|PHA ||pseudohypoaldosteronism ||seudohipoaldosteronismo |\n|PHG ||parahippocampal gyrus ||circunvoluci\u00f3n parahipoc\u00e1mpica |\n|PHN ||postherpetic neuralgia ||neuralgia posherp\u00e9tica |\n|PHP ||pseudohypoparathyroidism ||seudohipoparatiroidismo |\n|PHT ||postmenopausal hormone therapy ||tratamiento de sustituci\u00f3n hormonal en posmenop\u00e1usicas |\n|PI ||phosphatydylinositol ||fosfatidilinositol |\n|PI ||protease inhibitor ||inhibidor de la proteasa |\n|p-i ||pharmaco-immune ||farmacoinmunitario |\n|PIA ||proliferative inflammatory atrophy ||atrofia inflamatoria proliferativa |\n|PI3K ||phosphatidylinositol-3 kinase ||fosfatilidinositol-3-cinasa |\n|PI-5K ||phosphoinositide 5-kinase ||fosfoinositido 5-cinasa |\n|PICA ||posterior inferior cerebellar artery ||arteria cerebelosa posteroinferior |\n|PICC ||peripherally inserted central catheter ||cat\u00e9ter central insertado por v\u00eda perif\u00e9rica |\n|PID ||pelvic inflammatory disease ||enfermedad inflamatoria p\u00e9lvica |\n|PID ||primary immunodeficiency ||inmunodeficiencia primaria |\n|PIE ||pulmonary infiltrates with eosinophilia ||infiltrados pulmonares con eosinofilia |\n|PIGN ||postinfectious glomerulonephritis ||glomerulonefritis posinfecciosa |\n|PIN ||prostatic intraepithelial neoplasia ||neoplasia prost\u00e1tica intraepitelial |\n|Pio2 ||partial pressure of inspired oxygen ||presi\u00f3n parcial de ox\u00edgeno inspirado |\n|PIOPED ||Prospective Investigation of Pulmonary Embolism Diagnosis || |\n|PIP ||proximal interphalangeals ||interfal\u00e1ngicas proximales |\n|PIP2 ||phosphatidylinositol bisphosphate ||difosfato de fosfatidilinositol |\n|PIP3 ||phosphatidylinositol triphosphate ||fosfatidilinositol trifosfato |\n|PIRO ||predisposition-infection-response-organ dysfunction ||predisposici\u00f3n-infecci\u00f3n-respuesta-disfunci\u00f3n \u00f3rganica |\n|PIRRT ||prolonged intermittent renal replacement therapy ||tratamiento de sustituci\u00f3n prolongado intermitente de la funci\u00f3n renal |\n|PISA ||isovelocity surface area ||\u00e1rea de la superficie de isovelocidad |\n|PIVKA-2 ||protein induced by vitamin K absence ||prote\u00edna inducida por la ausencia de vitamina K |\n|PJRT ||permanent junctional reciprocating tachicardia ||taquicardia rec\u00edproca permanente de uni\u00f3n |\n|PJI ||periprosthetic join infection ||infecci\u00f3n periprot\u00e9sica articular |\n|PK ||prekallikrein ||precalicre\u00edna |\n|PK ||pericardial knock ||choque peric\u00e1rdico |\n|PKA ||protein kinase A ||prote\u00edna cinasa A |\n|PKAN ||pantotenate kinase-associated-neurodegeneration ||neurodegeneraci\u00f3n vinculada con pantotenato cinasa |\n|PKC ||protein kinase C ||prote\u00edna cinasa C |\n|PKD ||polycystic kidney disease ||enfermedad de ri\u00f1\u00f3n poliqu\u00edstico |\n|PKHD1 ||polycystic kidney and hepatic disease 1 ||enfermedad poliqu\u00edstica de ri\u00f1\u00f3n e h\u00edgado 1 |\n|PKDL ||post kala-azar termal leishmeniasis ||leishmaniosis d\u00e9rmica posterior a kala-azar |\n|PL ||plasma level ||concentraci\u00f3n en plasma |\n|PL ||phospholipids ||fosfol\u00edpidos |\n|PL ||phospholamban ||fosfolambano |\n|PLA2 ||phospholipase A2 ||fosfolipasa A2 |\n|PLC ||phospholipase C ||fosfolipasa C |\n|PLCH ||pulmonary Langerhans cell histiocytosis ||histiocitosis pulmonar de c\u00e9lulas de Langerhans |\n|PLC\u03b2 ||phospholipase C\u03b2 ||fosfolipasa C\u03b2 |\n|PLE ||polymorphous light eruption ||erupci\u00f3n lum\u00ednica polimorfa |\n|PLE ||panlobular emphysema ||enfisema panlobulillar |\n|PLED ||periodic lateralized epileptiform discharges ||descargas epileptiformes lateralizadas peri\u00f3dicas |\n|PLCO ||prostate, Lung, Colorectal and Ovarian || |\n|PlGF ||placenta-derived growth factor ||factor de crecimiento derivado de la placenta |\n|PKA ||protein kinase A ||prote\u00edna cinasa A |\n|PLMD ||periodic limb movement disorder ||trastorno por movimiento peri\u00f3dico de las extremidades |\n|PLMS ||periodic limb movements of sleep ||movimientos peri\u00f3dicos de las extremidades durante el sue\u00f1o |\n|PLP ||5\u2032-pyridoxal phosphate ||fosfato de 5\u2032-piridoxal |\n|PLR ||passive leg raise ||elevaci\u00f3n pasiva de la pierna |\n|PLS ||primary lateral sclerosis ||esclerosis lateral primaria |\n|PLV ||partial liquid ventilation ||ventilaci\u00f3n parcial con l\u00edquidos |\n|PM ||polymyositis ||polimiositis |\n|PM ||poor metabolizers ||metabolizadores deficientes |\n|PMBC ||peripheral blood mononuclear cells ||mononucleares de sangre perif\u00e9rica |\n|PMBC ||percutaneous mitral ballon commisurotomy ||valvuloplastia mitral percut\u00e1nea con globo |\n|PMC ||pseudomembranous colitis ||colitis seudomembranosa |\n|PME ||progressive myoclonus epilepsy ||epilepsia miocl\u00f3nica progresiva |\n|PMF ||progressive massive fibrosis ||fibrosis masiva progresiva |\n|PML ||progressive multifocal leukoencephalopathy ||leucoencefalopat\u00eda multifocal progresiva |\n|PML ||promyelocytic leukemia ||leucemia promieloc\u00edtica |\n|PMLE ||polymorphous light eruption ||exantema polimorfo solar |\n|PML-RAR\u03b1 || ||receptor \u03b1 para \u00e1cido retinoico de leucemia promieloc\u00edtica |\n|PMN ||polymorphonuclear neutrophils (leukocytes) ||leucocitos polimorfonucleares |\n|PMP22 ||peripheral myelin protein 22 ||prote\u00edna miel\u00ednica perif\u00e9rica 22 |\n|PMR ||polymyalgia rheumatica ||polimialgia reum\u00e1tica |\n|pMRI ||perfusion magnetic resonance imaging ||im\u00e1genes por resonancia magn\u00e9tica de perfusi\u00f3n |\n|PN ||parenteral nutrition ||nutrici\u00f3n parenteral |\n|PN ||proteostasis network ||red de proteostasis |\n|PN ||pelvic nodes ||ganglios linf\u00e1ticos p\u00e9lvicos |\n|PN ||piecemeal necrosis ||necrosis en sacabocados |\n|PNa ||plasma sodium ||concentraci\u00f3n plasm\u00e1tica de sodio |\n|PND ||paraneoplastic neurologic disorders ||trastornos neurol\u00f3gicos paraneopl\u00e1sicos |\n|PND ||paroxysmal nocturnal dyspnea ||disnea parox\u00edstica nocturna |\n|PNDS ||postnasal drip syndrome ||s\u00edndrome de goteo posnasal |\n|PNET ||primitive neuroectodermal tumors ||tumores neuroectod\u00e9rmicos primitivos |\n|PNH ||paroxysmal nocturnal hemoglobinuria ||hemoglobinuria parox\u00edstica nocturna |\n|PNH ||peripheral nerve hyperexcitability ||hiperexcitabilidad del nervio perif\u00e9rico |\n|PNP ||paraneoplastic pemphigus ||p\u00e9nfigo paraneopl\u00e1sico |\n|PNP ||purine nucleoside phosphorylase ||purina nucle\u00f3sido fosforilasa |\n|PNPLA6 || ||Prote\u00edna 6 que contiene el dominio de la fosfolipasa tipo patatina |\n|PNR ||photoreceptor-specific nuclear receptor ||receptor nuclear espec\u00edfico de fotorreceptor |\n|PNTML ||pudendal nerve terminal motor latency ||latencia motora terminal de nervio pudendo |\n|PO ||per oris ||v\u00eda oral |\n|Po2 ||partial pressure of oxygen ||presi\u00f3n parcial de ox\u00edgeno |\n|POA ||pyrazionic acid ||\u00e1cido pirazinoico |\n|POCUS ||point-of-care ultrasound ||ecograf\u00eda en el punto de atenci\u00f3n |\n|POEM ||percutaneous endoscopic gastrostomy ||gastrostom\u00eda endosc\u00f3pica percut\u00e1nea |\n|POEMS ||polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes ||polineuropat\u00eda, organomegalia, gammapat\u00eda monoclonal y alteraciones cut\u00e1neas |\n|POF ||premature ovarian failure ||insuficiencia ov\u00e1rica prematura |\n|POHS ||presumed ocular histoplasmosis syndrome ||s\u00edndrome de histoplasmosis ocular supuesta |\n|POI ||premature ovarian insufficiency ||insufuciencia ov\u00e1rica prematura |\n|POLST ||Physician Orders for Life-Sustaining Treatment ||\u00f3rdenes del m\u00e9dico para emprender medidas para prolongar la vida\u201d |\n|POMC ||pro-opiomelanocortin ||proopiomelanocortina |\n|POME ||pulmonary oil microembolism ||microembolia pulmonar grasa |\n|POMGNT1 ||Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 ||manosa beta unida a O 1,2-N-acetilglucosaminiltransferasa |\n|POMT ||Protein O-mannosyl-transferase ||prote\u00edna-O-manosiltransferasa |\n|PORN ||progressive outer retinal necrosis ||necrosis retiniana externa progresiva |\n|PORT ||Pneumonia Patient Outcomes Research Team || |\n|POST ||Prevention of Syncope Trial || |\n|POTS ||postural orthostatic tachycardia syndrome ||s\u00edndrome de taquicardia ortost\u00e1tica postural |\n|PP ||pancreatic peptide ||p\u00e9ptido pancre\u00e1tico |\n|PP ||periodic paralisys ||par\u00e1lisis peri\u00f3dica |\n|PP ||phosphorylated ||fosforilado |\n|PPA ||primary progressive aphasia ||afasia progresiva primaria |\n|PPAR ||peroxisome proliferator activated receptor ||receptor activado por el proliferador de peroxisomas |\n|PPAR-\u03b1 ||peroxisome proliferator-activated receptor-alpha ||receptor activado por el proliferador de peroxisomas alfa |\n|PPAR-\u03b3 ||peroxisome proliferator-activated receptor gamma ||receptor activado por el proliferador de peroxisomas gamma |\n|PPAR\u03b31 ||peroxisome-proliferator activated receptor \u03b31 ||receptor activado por el proliferador de peroxisoma \u03b31 |\n|PPC ||posterior parietal cortex ||corteza parietal posterior |\n|PPCM ||peripartum cardiomyopathy ||miocardiopat\u00eda periparto |\n|PPD ||purified protein derivative ||derivado prote\u00ednico purificado |\n|PPH ||primary pulmonary hypertension ||hipertensi\u00f3n pulmonar primaria |\n|PPHP ||pseudopseudohypoparathyroidism ||seudoseudohipoparatiroidismo |\n|PPHT ||portopulmonary hypertension ||hipertensi\u00f3n portopulmonar |\n|PPi ||inorganic pyrophosphate ||pirofosfato inorg\u00e1nico |\n|PPI ||proton pump inhibitor ||inhibidor de la bomba de protones |\n|PPK ||palmoplantar keratoderma ||queratodermia palmoplantar |\n|PPL ||proteolipid protein ||prote\u00edna proteolip\u00eddica |\n|PPMS ||primary progressive multiple sclerosis ||esclerosis m\u00faltiple progresiva primaria |\n|PPN ||pedunculopontine nucleus ||n\u00facleo pedunculopontino |\n|PPNAD ||primary pigmented nodular adrenal disease ||enfermedad suprarrenal nodular pigmentada primaria |\n|PPNG ||Penicillinase-producing N. gonorrhoeae ||N. gonorrhoeae productora de penicilinasas |\n|PPS ||pentosan polysulfate sodium ||polisulfato s\u00f3dico de pentosano |\n|PPSC ||primary peritoneal papillary serous carcinoma ||carcinoma seroso papilar peritoneal primario |\n|PPSV ||pneumococcal polysaccharide vaccination ||vacuna de polisac\u00e1rido neumoc\u00f3cico |\n|PSC ||primary sclerosing cholangitis ||colangitis esclerosante primaria |\n|PPV ||pneumococcal polysaccharide vaccine ||vacuna con polisac\u00e1rido neumoc\u00f3cico |\n|PPV ||positive predictive value ||valor predictivo positivo |\n|PVA ||prinzmetal variant angina ||angina variante de Prinzmetal |\n|PR ||prolonged release ||liberaci\u00f3n prolongada |\n|PR ||pulmonic regurgitation ||insuficiencia pulmonar |\n|PR ||partial response ||respuesta parcial |\n|PRA ||panel reactive antibody ||an\u00e1lisis de anticuerpo reactivo |\n|PRA ||phosphoribosylamine ||fosforribosilamina |\n|PRA ||plasma renin activity ||actividad de renina plasm\u00e1tica |\n|Prb ||retinoblastoma tumor-supressor protein ||prote\u00edna supresora de tumores del retinoblastoma |\n|PRBC ||packed red blood cell ||concentrado de eritrocitos |\n|PRCA ||pure red cell aplasia ||aplasia eritroc\u00edtica pura |\n|PrEP ||pre-expositure prophylaxis ||profilaxis anterior a la exposici\u00f3n |\n|PRES ||posterior reversible encephalopathy syndrome ||s\u00edndrome de encefalopat\u00eda posterior reversible |\n|PRK ||photorefractive keratectomy ||queratectom\u00eda de fotorrefracci\u00f3n |\n|PRKAG2 ||protein kinase, AMP-activated gamma 2 ||subunidad no catal\u00edtica gamma 2 activada por monofosfato de adenosina |\n|PRKAR1A ||R1\u03b1 regulatory subunit of protein kinase A ||subunidad reguladora R1\u03b1 de la proteina cinasa A |\n|PRL ||prolactin ||prolactina |\n|PRMS ||progressive/relapsing multiple sclerosis ||esclerosis m\u00faltiple progresiva-recidivante |\n|prn ||pro re nata ||por raz\u00f3n necesaria |\n|PROACT ||Prolyse in Acute Cerebral Thromboembolism II || |\n|PROK2 ||prokineticin 2 ||procineticina 2 |\n|PROKR2 ||prokineticin receptor 2 ||receptor de procineticina 2 |\n|PROMM ||proximal myotonic myopathy ||miopat\u00eda miot\u00f3nica proximal |\n|PROP1 || ||Profeta de PIT-1 |\n|PROTO ||protoporphyrinogen ||protoporfirin\u00f3geno |\n|PROVE-IT ||Pravastatin or Atorvastatin Evaluation and Infection Therapy || |\n|PRP ||polyribitol ribose phosphate ||fosfato de ribosa de polirribitol |\n|PrP ||prion protein ||prote\u00edna pri\u00f3nica |\n|PRPP ||phosphoribosylpyrophosphate ||fosforribosilpirofosfato |\n|PRR ||pattern recognition receptors ||receptores de reconocimiento de patrones |\n|PRS ||polygenic risk scores ||puntuaciones del riesgo polig\u00e9nico |\n|pRTA ||proximal renal tubular acidosis ||acidosis tubular renal proximal |\n|PRX ||periaxin ||periaxina |\n|Ps ||psoriasis ||psoriasis |\n|PS ||pulmonic stenosis ||estenosis pulmonar |\n|PS0 ||performance status 0 ||estado funcional cero del ECOG |\n|PSA ||prostate-specific antigen ||ant\u00edgeno prost\u00e1tico espec\u00edfico |\n|PsA ||psoriatic arthritis ||artritis psori\u00e1sica |\n|PsaA ||pneumococcal surface adhesin A ||adhesina de superficie neumoc\u00f3cica A |\n|PSAD ||prostate-specific antigen density ||densidad de ant\u00edgeno prost\u00e1tico espec\u00edfico |\n|PSB ||protected specimen brush ||cepillo protegido para muestras |\n|PSC ||peristriate cortex ||corteza periestriada |\n|PSC ||primary sclerosing cholangitis ||colangitis esclerosante primaria |\n|PSGN ||poststreptococcal glomerulonephritis ||glomerulonefritis posestreptoc\u00f3cica |\n|PSI ||Pneumonia Severity Index ||\u00cdndice de gravedad de la neumon\u00eda |\n|PSM ||presystolic murmur ||soplo presist\u00f3lico |\n|PSMA ||prostate specific membrane antigen ||ant\u00edgeno prost\u00e1tico espec\u00edfico de membrana |\n|PSMD ||peak width of the skeletonized mean diffusivity ||ancho m\u00e1ximo del histograma de difusividad promedio esqueletonizada |\n|PSN ||paraneoplastic sensory neuronopathy ||neuronopat\u00eda sensorial paraneopl\u00e1sica |\n|PSP ||progressive supranuclear palsy ||par\u00e1lisis supranuclear progresiva |\n|PspA ||pneumococcal surface protein A ||prote\u00edna de superficie neumoc\u00f3cica A |\n|PSRA ||post-streptococcal reactive arthritis ||artritis reactiva posestreptoc\u00f3cica |\n|PSS ||progressive systemic sclerosis ||esclerosis sist\u00e9mica progresiva |\n|PSTI ||pancreatic secretory trypsin inhibitor ||inhibidor de tripsina secretor pancre\u00e1tico |\n|PSU ||pilosebaceous units ||unidades piloseb\u00e1ceas |\n|PSV ||pressure-support ventilation ||ventilaci\u00f3n con apoyo de presi\u00f3n |\n|PSVT ||paroxysmal supraventricular tachycardia ||taquicardia parox\u00edstica supraventricular |\n|PT ||physical therapy ||fisioterapia |\n|PT ||prothrombin time ||tiempo de protrombina |\n|PTA ||percutaneous transluminal angiography ||angiograf\u00eda transluminal percut\u00e1nea |\n|PTB ||phosphotyrosine binding ||uni\u00f3n a fosfotirosina |\n|PTC ||papillary thyroid cancer ||c\u00e1ncer papilar de tiroides |\n|PTC ||percutaneous transhepatic cholangiography ||colangiograf\u00eda transhep\u00e1tica percut\u00e1nea |\n|PTCA ||percutaneous transluminal coronary angioplasty ||angioplastia coronaria transluminal percut\u00e1nea |\n|PTD ||partial tandem duplication ||duplicaci\u00f3n parcial en t\u00e1ndem |\n|PTD ||photodynamic therapy ||tratamiento fotodin\u00e1mico |\n|PTEN ||phosphatase and tensin homologue ||hom\u00f3logo de fosfatasa y tensina |\n|PTFE ||polytetrafluoroethylene ||politetrafluoroetileno |\n|PTH ||parathyroid hormone ||hormona paratiroidea |\n|PTHrP ||parathyroid hormone-related protein ||prote\u00edna vinculada con hormona paratiroidea |\n|PTHrP ||PTH-related peptide ||p\u00e9ptido relacionado con PTH |\n|PTHrP ||parathyroid hormone-related peptide ||P\u00e9ptido relacionado con la hormona paratiroidea |\n|PtHRP2 ||histidine-rich protein 2 ||prote\u00edna 2 rica en histidina |\n|PTK ||protein tyrosine kinase ||cinasa de prote\u00edna cinasa de tirosina |\n|PTP ||permeability transition pore ||poro de paso de la permeabilidad |\n|PTP ||protein tyrosine phosphatase ||fosfatasa de prote\u00edna cinasa de tirosina |\n|PTPN ||protein phosphotyrosine phosphatase ||prote\u00edna tirosina fosfatasa |\n|PTPN22 ||protein tyrosine phosphatase non-receptor 22 ||prote\u00edna del no receptor 22 de la tirosina fosfatasa |\n|PTRA ||percutaneous transluminal renal angioplasty ||angioplastia transluminal percut\u00e1nea renal |\n|PTSD ||post-traumatic stress disorder ||trastorno de estr\u00e9s postraum\u00e1tico |\n|PTT ||partial thromboplastin time ||tiempo parcial de tromboplastina |\n|PTT ||protein truncation tests ||pruebas de truncamiento de prote\u00ednas |\n|PTTG ||pituitary tumor transforming gene ||gen transformador de tumor hipofisario |\n|PTX ||pneumothorax ||neumot\u00f3rax |\n|PUBS ||percutaneous umbilical blood sampling ||muestra percut\u00e1nea de sangre umbilical |\n|PUD ||peptic ulcer disease ||\u00falcera p\u00e9ptica |\n|PUFA ||polyunsaturated fatty acids ||\u00e1cidos grasos poliinsaturados |\n|PUVA ||psoralen with ultraviolet A light ||psoralenos con luz ultravioleta A |\n|PV ||pemphigus vulgaris ||p\u00e9nfigo vulgar |\n|PV ||polycythemia vera ||policitemia verdadera |\n|PV ||portal vein ||vena porta |\n|PVC ||premature ventricular contractions ||extras\u00edstoles ventriculares |\n|PVC ||premature ventricular complexes ||extras\u00edstoles ventriculares |\n|PVD ||peripheral vascular disease ||vasculopat\u00eda perif\u00e9rica |\n|PVE ||prosthetic valve endocarditis ||endocarditis relacionada con pr\u00f3tesis valvulares |\n|PVL ||Panton-Valentine leukocidin ||leucocidina de Panton-Valentine |\n|PVN ||paraventricular nucleus ||n\u00facleo paraventricular |\n|PVNS ||pigmented villonodular synovitis ||sinovitis vellonodular pigmentada |\n|PVOD ||pulmonary venoocclusive disease ||enfermedad oclusiva venosa pulmonar |\n|PVP ||percutaneous vertebroplasty ||vertebroplastia percut\u00e1nea |\n|PVR ||postvoid residual ||orina residual despu\u00e9s de micci\u00f3n |\n|PVR ||pulmonary vascular resistance ||resistencia vascular pulmonar |\n|PVRV ||purified Vero cell vaccine ||vacuna de c\u00e9lulas Vero purificada |\n|PWID ||people who inject drugs ||personas que se inyectan drogas |\n|PWS ||Prader-Willi syndrome ||s\u00edndrome de Prader-Willi |\n|PXE ||pseudoxanthoma elasticum ||seudoxantoma el\u00e1stico |\n|PYY ||peptide YY ||p\u00e9ptido YY |", "language": null, "image": null, "pagetype": null, "links": ["#skipToMainContent", "javascript:;", "javascript:;", "https://access.mhmedical.com/umbrella-index.aspx", "javascript:;", "http://accessanesthesiology.mhmedical.com", "http://apn.mhmedical.com", "http://accessartmed.mhmedical.com", "http://accessbiomedicalscience.mhmedical.com", "http://accesscardiology.mhmedical.com", "http://dermatology.mhmedical.com", "http://accessemergencymedicine.mhmedical.com", "http://hemonc.mhmedical.com", "http://accessmedicina.mhmedical.com", "http://accessmedicine.mhmedical.com", "http://neurology.mhmedical.com", "http://obgyn.mhmedical.com", "http://accesspediatrics.mhmedical.com", "http://accesspharmacy.mhmedical.com", "http://accessphysiotherapy.mhmedical.com", "http://accesssurgery.mhmedical.com", "http://casefiles.mhmedical.com", "http://csm.mhmedical.com", "http://fadavisat.mhmedical.com", "http://fadavispt.mhmedical.com", "http://jamaevidence.mhmedical.com", "http://murtagh.mhmedical.com", "http://ommbid.mhmedical.com", "http://ppp.mhmedical.com", "javascript:;", "https://www.accessusercenter.com/channels/1606-accessmedicina", "https://access.mhmedical.com/ss/About_ES.aspx", "https://access.mhmedical.com/ss/ContactUs_ES.aspx", "https://access.mhmedical.com/public/feedback.aspx", "https://learn.mheducation.com/Access_Medicina.html", "javascript:;", "javascript:;", "javascript:;", "/ForgotPassword.aspx", "/ForgotUsername.aspx", "/ss/accessmysubscription_ES.aspx", "/SignInShibboleth.aspx?view=handler&redirecturl=http%3a%2f%2faccessmedicina.mhmedical.com%2fAcronym.aspx", "../SignInShibboleth.aspx?view=signin&federationID=27&redirecturl=http%3a%2f%2faccessmedicina.mhmedical.com%2fAcronym.aspx", "/", "javascript:;", "javascript:;", "javascript:;", "/books.aspx?view=library", "/book.aspx?bookid=865&TopLevelContentDisplayName=Lecturas", "/Diagnosaurus.aspx", "/book.aspx?bookid=2424&TopLevelContentDisplayName=Referencia%20r\u00e1pida", "/book.aspx?bookid=1945&TopLevelContentDisplayName=Gu\u00edas", "/calculator.aspx", "/books.aspx?view=2mm", "/Acronym.aspx", "/drugs.aspx", "/drugs.aspx", "/drugs.aspx?gbosContainerId=264", "/multimedia.aspx", "/multimedia.aspx#1175", "/multimedia.aspx#1459", "/multimedia.aspx#1486", "/multimedia.aspx#1432", "/multimedia.aspx#1500", "/multimedia.aspx#994", "/multimedia.aspx#995", "/multimedia.aspx#1341", "/multimedia.aspx#1392", "/infographics.aspx?gboscontainerID=275", "/cases.aspx", "/cases.aspx?groupid=1292", "/cases.aspx?groupid=1545", "/cases.aspx?gboscontainerid=200", "/cases.aspx?gboscontainerid=236", "/cases.aspx?gboscontainerid=283", "/qa.aspx", "/qa.aspx?groupid=1020", "/qa.aspx?groupid=1135", "/patientEdHandouts.aspx", "https://accessmedicina.mhmedical.com/ss/aboutSearch_ES.aspx", "javascript:;", "/account/MyAccess.aspx", null, "#", null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, "/index.aspx", "/books.aspx?view=library", "/Diagnosaurus.aspx", "/Diagnosaurus.aspx", "/book.aspx?bookid=2424&TopLevelContentDisplayName=Referencia%20r\u00e1pida", "/book.aspx?bookid=1945&TopLevelContentDisplayName=Gu\u00edas", "/calculator.aspx", "/books.aspx?view=2mm", "/Acronym.aspx", "/drugs.aspx", "/drugs.aspx", "/drugs.aspx?gbosContainerId=264", "/multimedia.aspx#1175", "/multimedia.aspx#1175", "/multimedia.aspx#1459", "/multimedia.aspx#1486", "/multimedia.aspx#1432", "/multimedia.aspx#1500", "/multimedia.aspx#994", "/multimedia.aspx#995", "/multimedia.aspx#1341", "/multimedia.aspx#1392", "/infographics.aspx?gboscontainerID=275", "/cases.aspx?groupid=1292", "/cases.aspx?groupid=1292", "/cases.aspx?groupid=1545", "/cases.aspx?gboscontainerid=200", "/cases.aspx?gboscontainerid=236", "/cases.aspx?gboscontainerid=283", "/qa.aspx?groupid=1020", "/qa.aspx?groupid=1020", "/qa.aspx?groupid=1135", "/patientEdHandouts.aspx", "/SS/About_ES.aspx", "https://access.mhmedical.com/umbrella-main.aspx", null, "https://accessanesthesiology.mhmedical.com", "https://apn.mhmedical.com", "https://accessartmed.mhmedical.com", "https://accessbiomedicalscience.mhmedical.com", "https://accesscardiology.mhmedical.com", "https://dermatology.mhmedical.com", "https://accessemergencymedicine.mhmedical.com", "https://hemonc.mhmedical.com", "https://accessmedicina.mhmedical.com", "https://accessmedicine.mhmedical.com", "https://neurology.mhmedical.com", "https://obgyn.mhmedical.com", "https://accesspediatrics.mhmedical.com", "https://accesspharmacy.mhmedical.com", "https://accessphysiotherapy.mhmedical.com", "https://accesssurgery.mhmedical.com", "https://casefiles.mhmedical.com", "https://csm.mhmedical.com", "https://fadavisat.mhmedical.com", "https://fadavispt.mhmedical.com", "https://jamaevidence.mhmedical.com", "https://murtagh.mhmedical.com", "https://ommbid.mhmedical.com", "https://ppp.mhmedical.com", null, "https://www.accessusercenter.com/channels/1606-accessmedicina", "https://access.mhmedical.com//ss/About_ES.aspx", "https://access.mhmedical.com//ss/ContactUs_ES.aspx", "https://access.mhmedical.com//public/feedback.aspx", null, "https://learn.mheducation.com/Access_Medicina.html", "https://store.mhmedical.com/subscriptionOptions.aspx?siteid=143", "https://www.mhprofessional.com", "/ss/terms_ES.aspx", "http://www.mheducation.com/privacy", "/ss/notice_ES.aspx", "/ss/BrowserSupport_ES.aspx", "https://silverchair.com", "javascript:;", "https://www.mheducation.com/privacy.html", "javascript:void CookieAcceptance();"]}